Answers are grounded in this paper and cite their sources.
In this issue of Blood, Matafonov et al demonstrate that an inhibiting monoclonal antibody against coagulation factor XII (fXII) reduces fibrin formation and platelet accumulation in a primate thrombosis model.1
No takes yet. Share an insight, caveat, or question.
Joost C.M. Meijers (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: